There's a catch. Most of these companies still rely on local chartered accountants or regional bankers for deal advice. That works fine for domestic transactions. It falls apart the moment a deal crosses a border, because foreign regulatory approvals, currency structuring, and cross-cultural negotiation require a completely different skill set.
Indian outbound M&A hit its highest deal count since 2012 in 2024, according to Grant Thornton Bharat's Annual Dealtracker 2025. Ahmedabad's businesses are part of that wave. This article looks at why specialized cross-border advisory matters and how Transjovan Capital, a 15-year-old global Corporate Development firm, supports the city's most ambitious enterprises.
Key Takeaways
- Ahmedabad's chemicals, pharma, and engineering firms are expanding globally for technology and markets
- Cross-border M&A needs regulatory, currency, and negotiation skills most local firms lack
- Transjovan's CDaaS model delivers continuous, partner-led support instead of one-time deals
- New York, Paris, Sydney, and Delhi offices give Ahmedabad firms direct global access
- A 15-year, USD 15+ billion track record backs the firm's execution credibility
Why Ahmedabad's Growing Enterprises Need Specialized Cross-Border M&A Advisory
Gujarat's industrial base reads like a checklist for global trade:
- Supplies 46.16% of India's chemical exports, worth roughly USD 12.8 billion in FY25
- Houses over 1,800 ceramic manufacturing units in Morbi alone, producing up to 90% of India's ceramic tiles
- Produces 65-70% of India's denim output
- Handles 72% of the world's diamond processing
Ahmedabad sits at the centre of this ecosystem, with pharma, textiles, engineering, and plastics flagged by the DGFT as products with strong export potential. Naturally, companies here aren't just exporting anymore. They're buying.
From Exporting to Acquiring
Ahmedabad-based Zydus Lifesciences acquired UK-based LiqMeds Group for GBP 68 million upfront, plus milestone-linked earn-outs through 2026, to enter the UK's oral-liquid pharmaceutical market. The Zydus-LiqMeds deal is a good example of what's coming: mid-sized Indian companies buying capability, not just capacity, abroad.
The Gap Local Advisors Can't Close
Regional CAs and bankers are excellent at domestic compliance and valuation. Cross-border deals ask for something different:
- Structuring across multiple currencies and tax jurisdictions
- Navigating foreign regulatory regimes like CFIUS in the US or EU merger control
- Managing negotiation styles that differ sharply from Indian boardroom norms
- Coordinating due diligence teams across time zones in real time
Get any of this wrong, and the fallout is expensive. Mispriced valuations, stalled regulatory clearances, and failed post-merger integration are the most common ways outbound deals unravel. A locally-limited advisor simply isn't built to catch these risks before they become deal-breakers.
What Makes Transjovan Capital Ahmedabad's Trusted Cross-Border M&A Partner
Transjovan Capital was built specifically for this gap. Founded in 2011, the firm has advised 250+ clients on cumulative transactions exceeding USD 15 billion, working across four continents rather than one region.
Partner-Led, Not Analyst-Led
Senior operators run every mandate from start to finish. The team includes ex-CEOs, CFOs, board members, and former Big-4 bankers. Managing Partner Gaurav Asthana brings 21+ years of cross-border M&A experience and has served as a retained buy-side advisor for corporations including Blackstone, Mahindra, Legrand, and Cummins.
For Ahmedabad's founder-led and family-run businesses, this matters. Most of these companies run lean leadership teams. A promoter can't personally chase down a CFIUS filing while also running daily operations.
Corporate Development as a Service
This is where Transjovan's CDaaS model comes in. Instead of a one-off transaction engagement, CDaaS acts as an embedded, multi-year Corporate Development function. It covers:
- Strategy and target identification
- Buy-side M&A execution
- Day-1 readiness planning
- Post-merger integration and synergy governance
The model measures success through synergy capture rather than deal count. That distinction matters for promoters seeking a long-term partner, not a one-time vendor relationship.
A Global Footprint With Real Weight
The firm operates from New York, Paris, Sydney, and New Delhi, giving Ahmedabad clients direct access to buyers, investors, and regulatory expertise across the US, Europe, and APAC. That footprint is reinforced by recognition as "Best M&A Advisory Firm in India" (2024) and active membership in the Indo-American, Indo-French, and Indo-German Chambers of Commerce and TiE Global.
For a promoter negotiating a first cross-border deal, that network often shortens the path to the right buyer or investor.
Industries in Ahmedabad We Help Go Global
Ahmedabad's economy maps closely onto Transjovan's sector expertise. The firm's coverage spans:
- Chemicals - a natural fit given Gujarat's dominance in Indian chemical exports
- Engineering & Auto - supporting the city's component and capital goods manufacturers
- Advanced Manufacturing - matches Ahmedabad's growing precision manufacturing base
- Consumer/FMCG - aligned with Gujarat's textile and consumer goods companies
- Building Materials - connecting to clusters like Morbi's ceramics industry
- Energy & Infrastructure/Renewables - relevant given Gujarat's push into solar and wind capacity
The team's domain depth reflects this specialization. Atishay Jain, who leads Renewables and has worked with organizations like Fortum, brings hands-on clean energy transaction experience applicable to Gujarat's expanding solar and wind sector.
Deoki Muchhal, who leads Consumer and previously served as MD and CFO at Cargill India, brings operator-level FMCG and consumer goods experience relevant to the state's textile and consumer companies.
Beyond established industrial players, the firm also supports Ahmedabad's emerging fintech and D2C companies pursuing growth capital raises or strategic acquisitions as they scale beyond domestic borders.
Our Cross-Border M&A Advisory Process
Cross-border deals don't move in a straight line. Transjovan structures its process into five stages, each designed to catch problems before they derail a transaction:
- **Strategic mandate scoping and target identification** - defining acquisition criteria and mapping the whitespace before any outreach begins
- Cross-border due diligence and valuation - applying arm's-length methodology adjusted for jurisdiction-specific rules and currency exposure
- **Deal structuring and regulatory navigation** - managing filings across regimes like CFIUS or EU merger control alongside India's ODI reporting requirements
- Negotiation and closing - bridging cultural and communication gaps that often trip up first-time cross-border acquirers
- Post-merger integration support - running synergy tracking dashboards and quarterly board-ready reporting to keep value realization on track
Regulatory timelines alone can add months to a deal. The US Treasury's CFIUS process involves review periods running 30 to 45 days per stage—before any Presidential action window even opens. According to the 2024 CFIUS Annual Report, the committee handled 116 declarations and 209 notices in 2024 alone. An advisor who hasn't navigated this before will underestimate the clock every time.
Transjovan runs both buy-side and sell-side mandates, including retained buy-side engagements for global corporations. The firm's CDaaS structure means this process doesn't end at closing. It continues into long-term synergy capture, creating a strategic partnership rather than just a transaction-only advisory relationship.
Global Reach, Local Understanding: Bridging Ahmedabad to the World
Ahmedabad doesn't have a Transjovan branch office, and that's by design. The firm's model was built around direct engagement rather than local real estate.
Offices in New York, Paris, and Sydney sit alongside the New Delhi headquarters. This footprint gives the team real-time access to local buyers, regulators, and market intelligence in exactly the geographies Ahmedabad companies tend to target:
- United States - for technology acquisitions and market entry
- Europe - for JVs and strategic partnerships in chemicals, engineering, and pharma
- APAC - for supply chain and manufacturing expansion
Ahmedabad promoters receive dedicated support through a mix of on-site visits and virtual advisory, so the absence of a local branch doesn't translate into a diluted service experience. The firm's service areas (India, US, Europe, and APAC) align directly with where Ahmedabad's chemicals, pharma, and engineering companies are already looking to expand.
Frequently Asked Questions
Does Transjovan Capital have a physical office in Ahmedabad?
No. The firm is headquartered in New Delhi with offices in New York, Paris, and Sydney. Ahmedabad clients are engaged through on-site visits and virtual advisory, ensuring full support without a local branch.
What types of cross-border transactions does Transjovan handle for Ahmedabad companies?
The firm covers buy-side, sell-side, joint venture, and growth capital transactions, typically ranging from USD 100 million to over USD 1 billion.
How is cross-border M&A different from domestic M&A?
Cross-border deals add foreign regulatory approvals, currency and tax structuring, arm's-length valuation requirements, and cross-cultural negotiation dynamics that domestic transactions don't involve.
Which Ahmedabad industries benefit most from cross-border M&A advisory?
Chemicals, pharmaceuticals, engineering, textiles, and renewables show the strongest global deal potential given Gujarat's export-heavy industrial base.
What is the CDaaS model and how does it help Ahmedabad businesses?
CDaaS is an embedded, multi-year Corporate Development engine that reduces the burden on promoters and CXOs while keeping the business deal-ready on an ongoing basis.
How long does a typical cross-border M&A transaction take to close?
Timelines run 6 to 12 months, depending on deal complexity, regulatory approvals, and the scope of cross-border due diligence required.
